GMHC Treatment Issues 1991 Dec 15; 5(9): 5
On Halloween, 1991, Hoffmann-LaRoche announced the completion
of the New Drug Application filing process for ddC (trade name
HIVID). The company is seeking approval for the treatment af
HIV-infected persons who have failed or are intolerant to AZT.
Additionally, the company is seeking approval of ddC as a first
line therapy for HIV in combination with AZT.
Copyright (c) 1991 - Gay Men's Health Crisis. Non-commercial
reproduction encouraged. Distributed by AEGIS, your online
gateway to a world of people, knowledge, and resources. Direct
Dial: v.34+: 714.248.2836; v.120/ISDN: 714.248.0433 Internet:
telnet:aegis.com www: www.aegis.com